Related references
Note: Only part of the references are listed.The Spectrum of Ocular Alterations in Patients with β-Thalassemia Syndromes Suggests a Pathology Similar to Pseudoxanthoma Elasticum
Giulio Barteselli et al.
OPHTHALMOLOGY (2014)
MULTIMODAL IMAGING IN DEFEROXAMINE RETINOPATHY
Francesco Viola et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Deferoxamine retinopathy: spectral domain-optical coherence tomography findings
Cheng-Hsiu Wu et al.
BMC OPHTHALMOLOGY (2014)
Accuracy of the Heidelberg Spectralis in the Alignment Between Near-Infrared Image and Tomographic Scan in a Model Eye: A Multicenter Study
Giulio Barteselli et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Desferrioxamine-related ocular toxicity: A case report
Sumu Simon et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2012)
Abnormal Fundus Autofluorescence Results of Patients in Long-term Treatment with Deferoxamine
Francesco Viola et al.
OPHTHALMOLOGY (2012)
Iron-Chelating Therapy for Transfusional Iron Overload
Gary M. Brittenham
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Deferoxamine mesylate is toxic for retinal pigment epithelium cells in vitro, and its toxicity is mediated by p38
Alexa Klettner et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2010)
Macular vitelliform lesion in desferrioxamine-related retinopathy
Mohamed A. Genead et al.
DOCUMENTA OPHTHALMOLOGICA (2010)
Deferoxamine-related ocular toxicity - Incidence and outcome in a pediatric population
Jasrajbir S. Baath et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Effects of desferoxamine on retinal and visual function
Ming Lu et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine
Ulrich Kellner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
A novel zinc compound (zinc monocysteine) enhances the antioxidant capacity of human retinal pigment epithelial cells
David J. Tate et al.
CURRENT EYE RESEARCH (2006)
Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion
TYY Lai et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients
SH Chen et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Classification of fundus autofluorescence patterns in early age-related macular disease
A Bindewald et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy
PJ Kertes et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2004)
Desferrioxamine related maculopathy: A case report
A Arora et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
EOG as a monitor of desferrioxamine retinal toxicity
RR Hidajat et al.
DOCUMENTA OPHTHALMOLOGICA (2004)
Bilateral vitelliform maculopathy and deferoxamine toxicity
CR Gonzales et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2004)
Bull's eye maculopathy with deferoxamine
V Bansal et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia
YL Chan et al.
PEDIATRIC RADIOLOGY (2002)
The expanded clinical spectrum of deferoxamine retinopathy
R Haimovici et al.
OPHTHALMOLOGY (2002)
Share Paper
